Hikma Pharmaceuticals PLC banner

Hikma Pharmaceuticals PLC
LSE:HIK

Watchlist Manager
Hikma Pharmaceuticals PLC Logo
Hikma Pharmaceuticals PLC
LSE:HIK
Watchlist
Price: 1 267 GBX 1.77% Market Closed
Market Cap: £2.8B

Cash Flow Statement

Cash Flow Statement
Hikma Pharmaceuticals PLC

Rotate your device to view
Cash Flow Statement
Currency: USD
Dec-2005 Jun-2006 Dec-2006 Jun-2007 Dec-2007 Jun-2008 Dec-2008 Jun-2009 Dec-2009 Jun-2010 Dec-2010 Jun-2011 Dec-2011 Jun-2012 Dec-2012 Jun-2013 Dec-2013 Jun-2014 Dec-2014 Jun-2015 Dec-2015 Jun-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024 Dec-2024 Jun-2025 Dec-2025
Operating Cash Flow
Net Income
64
68
76
83
84
74
64
75
95
112
121
93
94
112
132
186
298
405
362
313
318
231
210
227
(738)
(697)
293
378
491
539
558
603
544
440
233
220
281
367
455
462
519
Depreciation & Amortization
10
11
14
18
23
31
33
33
34
36
38
41
47
54
59
67
75
71
72
72
73
93
112
125
136
127
109
111
99
75
91
97
145
196
372
419
259
219
168
173
238
Stock-Based Compensation
1
0
1
1
2
2
3
4
5
5
4
6
8
8
8
8
7
7
8
0
15
0
22
0
22
0
21
0
24
0
27
43
29
23
22
22
25
30
27
28
23
Other Non-Cash Items
3
(1)
0
5
11
18
21
19
17
12
21
34
42
48
47
62
69
53
53
63
70
69
142
170
1 116
1 104
116
99
34
38
84
78
108
128
112
121
117
149
201
98
54
Cash Taxes Paid
18
16
19
21
18
12
8
13
16
24
33
20
2
12
25
43
84
112
79
57
51
43
76
109
103
61
63
66
108
103
61
130
129
85
55
77
129
99
125
149
124
Cash Interest Paid
5
5
5
6
10
15
17
15
13
13
14
17
24
30
36
39
37
34
38
40
49
61
54
51
57
54
51
52
44
43
39
40
50
52
68
80
82
81
84
83
83
Change in Working Capital
(46)
(37)
(54)
(76)
(65)
(67)
(43)
(21)
(27)
(12)
(28)
(62)
(57)
(60)
(54)
(42)
(105)
(129)
(62)
(98)
(95)
(53)
(171)
(103)
(71)
(131)
(88)
(156)
(152)
(78)
(269)
(382)
(159)
(181)
(187)
(177)
(49)
(151)
(260)
(206)
(375)
Cash from Operating Activities
33
N/A
42
+27%
35
-15%
30
-16%
53
+81%
55
+3%
75
+37%
106
+41%
119
+12%
148
+24%
153
+3%
106
-30%
126
+19%
154
+22%
184
+19%
273
+48%
337
+23%
401
+19%
425
+6%
350
-18%
366
+5%
340
-7%
293
-14%
419
+43%
443
+6%
403
-9%
430
+7%
432
+0%
472
+9%
577
+22%
464
-20%
396
-15%
638
+61%
583
-9%
530
-9%
583
+10%
608
+4%
584
-4%
564
-3%
527
-7%
436
-17%
Investing Cash Flow
Capital Expenditures
(24)
(41)
(52)
(46)
(55)
(67)
(66)
(49)
(40)
(49)
(53)
(69)
(78)
(95)
(89)
(62)
(75)
(101)
(118)
(115)
(137)
(181)
(190)
(168)
(151)
(145)
(139)
(152)
(186)
(205)
(224)
(217)
(229)
(254)
(225)
(213)
(204)
(205)
(235)
(299)
(317)
Other Items
8
(1)
(20)
(92)
(294)
(225)
(1)
3
3
(23)
(39)
(162)
(265)
(124)
(12)
(22)
(40)
(27)
(224)
(238)
(25)
(592)
(505)
79
0
16
43
56
35
7
(59)
(70)
(9)
(386)
(382)
(7)
(129)
(115)
(146)
(191)
(71)
Cash from Investing Activities
(16)
N/A
(42)
-159%
(73)
-72%
(139)
-90%
(349)
-152%
(292)
+16%
(66)
+77%
(46)
+30%
(38)
+18%
(71)
-89%
(92)
-29%
(231)
-151%
(343)
-49%
(219)
+36%
(101)
+54%
(84)
+17%
(115)
-38%
(128)
-11%
(342)
-167%
(353)
-3%
(162)
+54%
(773)
-377%
(695)
+10%
(89)
+87%
(151)
-70%
(129)
+15%
(96)
+26%
(96)
N/A
(151)
-57%
(198)
-31%
(283)
-43%
(287)
-1%
(238)
+17%
(640)
-169%
(607)
+5%
(220)
+64%
(333)
-51%
(320)
+4%
(381)
-19%
(490)
-29%
(388)
+21%
Financing Cash Flow
Net Issuance of Common Stock
125
125
2
2
3
161
161
2
2
5
3
3
2
1
1
2
(2)
(3)
0
0
1
1
0
0
0
0
0
0
0
(371)
(375)
(4)
0
(303)
(303)
0
0
0
(38)
(40)
(36)
Net Issuance of Debt
(14)
(36)
(8)
55
259
77
(107)
(0)
(49)
(34)
(27)
192
324
193
78
(111)
(143)
(15)
125
320
168
307
153
(185)
(78)
(156)
(141)
(71)
(10)
220
220
(29)
(114)
604
447
(239)
(103)
(46)
103
265
290
Cash Paid for Dividends
(18)
(12)
(7)
(12)
(13)
(14)
(14)
(14)
(16)
(21)
(23)
(25)
(25)
(25)
(27)
(32)
(39)
(53)
(55)
(63)
(64)
(72)
(77)
(80)
(79)
(81)
(84)
(92)
(97)
(107)
(109)
(114)
(120)
(125)
(125)
(124)
(137)
(159)
(175)
(177)
(185)
Other
(16)
(11)
(1)
(4)
(11)
(11)
(15)
(18)
(15)
(19)
(15)
(12)
(52)
(76)
(48)
(39)
(45)
(38)
(40)
(40)
(28)
(38)
(57)
(59)
(63)
(58)
(53)
(67)
(48)
(27)
(34)
(43)
(53)
(60)
(77)
(84)
(97)
(86)
(78)
(86)
(94)
Cash from Financing Activities
77
N/A
67
-14%
(14)
N/A
41
N/A
238
+482%
213
-11%
25
-88%
(31)
N/A
(78)
-156%
(69)
+12%
(61)
+11%
157
N/A
250
+59%
93
-63%
4
-96%
(181)
N/A
(229)
-27%
(110)
+52%
30
N/A
217
+623%
77
-65%
198
+157%
19
-90%
(324)
N/A
(220)
+32%
(295)
-34%
(278)
+6%
(230)
+17%
(155)
+33%
(285)
-84%
(298)
-5%
(190)
+36%
(287)
-51%
116
N/A
(58)
N/A
(447)
-671%
(337)
+25%
(291)
+14%
(188)
+35%
(38)
+80%
(25)
+34%
Change in Cash
Effect of Foreign Exchange Rates
1
(0)
1
2
(0)
0
0
(0)
0
3
(2)
(4)
(1)
(3)
(5)
(4)
(2)
(2)
(1)
(4)
(8)
(8)
(15)
(9)
0
(3)
(7)
(4)
0
(3)
(2)
(10)
(10)
(10)
(21)
(15)
(3)
(9)
(12)
1
6
Net Change in Cash
95
N/A
66
-31%
(50)
N/A
(66)
-34%
(57)
+14%
(24)
+59%
34
N/A
29
-15%
3
-90%
10
+257%
(3)
N/A
29
N/A
32
+12%
25
-22%
82
+230%
5
-94%
(9)
N/A
161
N/A
112
-30%
210
+88%
273
+30%
(243)
N/A
(398)
-64%
(3)
+99%
72
N/A
(24)
N/A
49
N/A
102
+108%
166
+63%
91
-45%
(119)
N/A
(91)
+24%
103
N/A
49
-52%
(156)
N/A
(99)
+37%
(65)
+34%
(36)
+45%
(17)
+53%
0
N/A
29
N/A
Free Cash Flow
Free Cash Flow
9
N/A
0
-98%
(17)
N/A
(17)
+3%
(2)
+90%
(13)
-642%
9
N/A
57
+501%
79
+38%
100
+27%
99
0%
37
-62%
48
+29%
60
+23%
95
+59%
211
+122%
262
+24%
300
+14%
307
+3%
235
-23%
229
-3%
159
-31%
103
-35%
251
+144%
292
+16%
258
-12%
291
+13%
280
-4%
286
+2%
372
+30%
240
-35%
179
-25%
409
+128%
329
-20%
305
-7%
370
+21%
404
+9%
379
-6%
329
-13%
228
-31%
119
-48%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett